New agents approved for treatment of acute staphylococcal skin infections

Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades. However, growing reservations about its efficacy led to an urgent need for new antibiotics effective against MRSA and other drug-resistant Staphylococcus aureus strains. This re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatarkiewicz, Jan, Staniszewska, Anna, Bujalska-Zadrożny, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108382/
https://www.ncbi.nlm.nih.gov/pubmed/27904526
http://dx.doi.org/10.5114/aoms.2016.59838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108382/
https://www.ncbi.nlm.nih.gov/pubmed/27904526
http://dx.doi.org/10.5114/aoms.2016.59838

Ejemplares similares